AAAAAA
Results:
1-8
|
Results: 8
Authors:
Escargueil, AE
Plisov, SY
Skladanowski, A
Borgne, A
Meijer, L
Gorbsky, GJ
Larsen, AK
Citation: Ae. Escargueil et al., Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatinremodeling, FASEB J, 15(10), 2001, pp. NIL_91-NIL_112
Authors:
Larsen, AK
Gilbert, C
Chyzak, G
Plisov, SY
Naguibneva, I
Lavergne, O
Lesueur-Ginot, L
Bigg, DCH
Citation: Ak. Larsen et al., Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells, CANCER RES, 61(7), 2001, pp. 2961-2967
Authors:
Larsen, AK
Escargueil, AE
Skladanowski, A
Citation: Ak. Larsen et al., Resistance mechanisms associated with altered intracellular distribution of anticancer agents, PHARM THERA, 85(3), 2000, pp. 217-229
Authors:
Escargueil, AE
Plisov, SY
Filhol, O
Cochet, C
Larsen, AK
Citation: Ae. Escargueil et al., Mitotic phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on Ser-1469, J BIOL CHEM, 275(44), 2000, pp. 34710-34718
Authors:
Scala, D
Escargueil, AE
Couprie, J
Larsen, AK
Citation: D. Scala et al., The catalytic activities of DNA topoisomerase II are most closely associated with the DNA cleavage/religation steps, BIOCHIMIE, 81(7), 1999, pp. 771-779
Authors:
Gobert, C
Skladanowski, A
Larsen, AK
Citation: C. Gobert et al., The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53, P NAS US, 96(18), 1999, pp. 10355-10360
Authors:
Come, MG
Bettaieb, A
Skladanowski, A
Larsen, AK
Laurent, G
Citation: Mg. Come et al., Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: Influence of drug transport abnormalities, INT J CANC, 81(4), 1999, pp. 580-587
Authors:
Come, MG
Skladanowski, A
Larsen, AK
Laurent, G
Citation: Mg. Come et al., Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells, BR J CANC, 79(7-8), 1999, pp. 1090-1097
Risultati:
1-8
|